Please login to the form below

Not currently logged in
Email:
Password:

US votes for low cost prescription drug imports

The US House of Representatives has passed a law that will allow the importation of lower-cost prescription drugs from regions outside the US, including Canada, Australia and Europe.

The US House of Representatives has passed a law that will allow the importation of lower-cost prescription drugs from regions outside the US, including Canada, Australia and Europe.

The legislation follows the passing of a USD 91bn spending measure, which funds farm subsidies and nutrition programmes for the budget year starting from October 2007.

The bill faces a veto from President Bush over its price tag, while the administration also opposes the drug importation provision. It says it would effectively permit individuals, wholesalers and pharmacists to import lower cost US-made and FDA-approved prescription drugs from Canada and other countries.

Under current law, US consumers are permitted to buy a 90-day supply in Canada.

Overseas drugs can cost two-thirds less than those in the US, where prices for brand-name drugs are among the highest globally. Outside the US, prices are lower because they are controlled by government regulation.

The White House says there is no system in place to protect consumers from counterfeit or unsafe drugs, but an administration policy statement stops short of an outright veto threat.

A move supported by drug companies to strike the drug importation provisions from the bill was defeated 283-146.

3rd August 2007

Share

COVID-19 Updates and Daily News

Featured jobs

PMHub

Add my company
Havas Lynx Group

We are the Havas Lynx Group. Devoted to fresh thinking. Changing the way the world does healthcare communications for the...

Latest intelligence

CHECKLIST 04: Let’s make your patient recruitment strategies a success
From how to generate insights to define your audience to drilling down those all-important key messages, our checklist has everything you need to think of, covered....
Multichannel engagement and the need for greater understanding of European markets
By Laurence Olding and Georgina James...
A snapshot of… Exscientia
...

Infographics